|GlaxoSmithKline plc -- USA Stock|| |
USD 34.99 0.25 0.71%
Ms. Victoria L. Whyte is Company Secretary of GlaxoSmithKline PLC., since 1 January 2011. She is a solicitor and a Fellow of the Institute of Chartered Secretaries and Administrators. Victoria was formerly Deputy Secretary and Secretary to the Remuneration Committee. She has acted as Secretary to the Board and all the Boards Committees since her appointment as Company Secretary on 1 January 2011.
Executive Since 2011
(44) 20 8047 7807 www.gsk.com
The company has Return on Asset of 6.7 %
which means that on every $100 spent on asset it made $6.7 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE)
of 64.55 %
implying that it generated $64.55 on every 100 dollars invested.
The company has 25.35 B in debt with debt to equity (D/E) ratio of 394.1 . This implies that the company may be unable to create cash to meet all of its financial commitments. GlaxoSmithKline plc has Current Ratio of 0.63 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, overthecounter medicines, and healthrelated consumer solutions worldwide. GlaxoSmithKline plc (GSK) is traded on New York Stock Exchange in USA. It is located in UNITED KINGDOM and employs 101,255 people. GlaxoSmithKline plc is listed under Pharmaceutical Products category by Fama And French industry classification.